Switzerlandlungcancereurope.eu
Lung Cancer Europe (LuCE) is a pan-European non-governmental organization and advocacy umbrella representing national and regional lung cancer patient groups across Europe. Headquartered in Bern, Switzerland, it serves as a platform for collaboration among member organizations to raise awareness, reduce stigma, and advocate for improved access to care, diagnostics, and treatments for those affected by or at risk of lung cancer.
Also known as Lung Cancer Europe.
EU marketing authorisation for tarlatamab as monotherapy for extensive‑stage small cell lung cancer after progression on platinum‑based chemo; Phase 3 showed survival gain.
